Bionano Genomics Inc (NASDAQ:BNGO) — Market Cap & Net Worth
Market Cap & Net Worth: Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (NASDAQ:BNGO) has a market capitalization of $12.87 Million ($12.87 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26238 globally and #5246 in its home market, demonstrating a -2.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bionano Genomics Inc's stock price $1.18 by its total outstanding shares 11092000 (11.09 Million). Analyse cash flow conversion of Bionano Genomics Inc to see how efficiently the company converts income to cash.
Bionano Genomics Inc Market Cap History: 2018 to 2026
Bionano Genomics Inc's market capitalization history from 2018 to 2026. Data shows change from $581.22 Million to $13.09 Million (-41.50% CAGR).
Index Memberships
Bionano Genomics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #753 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2473 of 3165 |
Weight: Bionano Genomics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bionano Genomics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bionano Genomics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.60x
Bionano Genomics Inc's market cap is 0.60 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $581.22 Million | $12.00 Million | -$18.50 Million | 48.43x | N/A |
| 2019 | $137.54 Million | $10.13 Million | -$29.84 Million | 13.58x | N/A |
| 2020 | $341.63 Million | $8.50 Million | -$41.14 Million | 40.18x | N/A |
| 2021 | $331.65 Million | $17.98 Million | -$72.44 Million | 18.44x | N/A |
| 2022 | $161.94 Million | $27.80 Million | -$132.60 Million | 5.82x | N/A |
| 2023 | $20.96 Million | $36.12 Million | -$232.49 Million | 0.58x | N/A |
| 2024 | $3.20 Million | $30.78 Million | -$112.02 Million | 0.10x | N/A |
| 2025 | $16.97 Million | $28.51 Million | -$26.39 Million | 0.60x | N/A |
Competitor Companies of BNGO by Market Capitalization
Companies near Bionano Genomics Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Bionano Genomics Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Bionano Genomics Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Bionano Genomics Inc's market cap moved from $581.22 Million to $ 13.09 Million, with a yearly change of -41.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.09 Million | -22.88% |
| 2025 | $16.97 Million | +430.51% |
| 2024 | $3.20 Million | -84.74% |
| 2023 | $20.96 Million | -87.05% |
| 2022 | $161.94 Million | -51.17% |
| 2021 | $331.65 Million | -2.92% |
| 2020 | $341.63 Million | +148.39% |
| 2019 | $137.54 Million | -76.34% |
| 2018 | $581.22 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Bionano Genomics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.87 Million USD |
| MoneyControl | $12.87 Million USD |
| MarketWatch | $12.87 Million USD |
| marketcap.company | $12.87 Million USD |
| Reuters | $12.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bionano Genomics Inc
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It als… Read more